Patel, Y.P.; Husereau, D.; Leighl, N.B.; Melosky, B.; Nam, J.
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients. Curr. Oncol. 2021, 28, 5278-5294.
https://doi.org/10.3390/curroncol28060441
AMA Style
Patel YP, Husereau D, Leighl NB, Melosky B, Nam J.
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients. Current Oncology. 2021; 28(6):5278-5294.
https://doi.org/10.3390/curroncol28060441
Chicago/Turabian Style
Patel, Yuti P., Donald Husereau, Natasha B. Leighl, Barbara Melosky, and Julian Nam.
2021. "Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients" Current Oncology 28, no. 6: 5278-5294.
https://doi.org/10.3390/curroncol28060441
APA Style
Patel, Y. P., Husereau, D., Leighl, N. B., Melosky, B., & Nam, J.
(2021). Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients. Current Oncology, 28(6), 5278-5294.
https://doi.org/10.3390/curroncol28060441